SARA COOPER: Open Payments
NPI 1932334745 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,842 in 17 payments from 9 companies in 2025. Trend: 2023 $2,554 · 2024 $15,167 · 2025 $3,842
Consulting: $1,800Speaker / faculty: $1,600Food & beverage: $379Education: $43Travel & lodging: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $3,621 |
| Abbott Laboratories | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Boston Scientific Corporation | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $20 |
| Almatica Pharma LLC | 1 | $14 |
Products named: ENHERTU, FREESTYLE LIBRE 3, KISQALI, WaveWriter Alpha Prime 16, Trodelvy, QUTENZA, ISTURISA, TERIPARATIDE.
Industry payments across CA — which companies pay providers there.
